Journal
TRANSLATIONAL RESEARCH
Volume 220, Issue -, Pages 153-166Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2020.03.010
Keywords
-
Categories
Funding
- National Health and Medical Research Council [APP1140617]
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R33AI121627]
Ask authors/readers for more resources
Wound infections associated with multidrug-resistant (MDR) bacteria are one of the important threats to public health. Bacteriophage (phage) therapy is a promising alternative or supplementary therapeutic approach to conventional antibiotics for combating MDR bacterial infections. In recent years, significant effort has been put into the development of phage formulations and delivery methods for topical applications, along with preclinical and clinical uses of phages for the treatment of acute and chronic wound infections. This paper reviews the application of phages for wound infections, with focus on the current status of phage formulations (including liquid, semi-solid and liposome-encapsulated formulations, phage-immobilized wound dressings), safety and efficacy assessment in clinical settings and major challenges to overcome.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available